Log inSign up
Image
user avatar
Ghassan Abou-Alfa
@GABOUALFA
@MSKCancerCenter Medical Oncologist, liver, cholangiocarcinoma, gallbladder, biliary cancer specialist. Global healthcare specialist. Patients’ advocate.
New York, USA
mskcc.org/cancer-care/do…
Joined November 2014
1,435
Following
5,594
Followers
  • user avatar
    Ghassan Abou-Alfa
    @GABOUALFA
    Oct 13, 2022
    What a delight seeing excellence being celebrated. Congratulations @EileenMOReilly for the @tcddublin #Burkitt medal. Your smile speaks millions of miles of beyond impressive #PancreaticCancer research and medical care from @tcddublin to @MSKCancerCenter @MSK_DeptOfMed
    Image
  • user avatar
    Ghassan Abou-Alfa
    @GABOUALFA
    Nov 13, 2022
    Thanks @LBpresidency @Najib_Mikati for bestowing @GABOUALFA Order of Honor of #Lebanon. Great honor to continue work @MSKCancerCenter @MSK_DeptOfMed for improving of #cancer #care for all. Congrats @AUB_Lebanon for help start global efforts. Thanks @FordhamLawNYC for enhancing
    Image
  • user avatar
    Ghassan Abou-Alfa
    @GABOUALFA
    Jun 2, 2022
    Great news for all patients with biliary tumors! Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer | NEJM Evidence
    Image
    evidence.nejm.org
    Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
    Patients with advanced biliary tract cancer have a poor prognosis, and first-line standard of care (gemcitabine plus cisplatin) has remained unchanged for more than 10 years. The TOPAZ-1 trial eval...
  • user avatar
    Ghassan Abou-Alfa
    @GABOUALFA
    Jun 2, 2023
    Congratulations @EileenMOReilly for the @MJHLifeSciences #giantsofcancer #2023 #gastrointestinalcancer . @MSKCancerCenter @MSK_DeptOfMed and we are all proud of you! Congratulations
    Image
    7.2K
  • user avatar
    Ghassan Abou-Alfa
    @GABOUALFA
    Oct 13, 2022
    After 82 years of excellence life span, Prof #Burkitt is reassured of his continued legacy . Congratulations @EileenMOReilly
    Image
  • user avatar
    Ghassan Abou-Alfa
    @GABOUALFA
    Oct 26, 2019
    Thank you @AUB_Lebanon @DrFadloKhuri for your peaceful support of #LebanonProtests this genuine effort for #Lebanon
    Image
    00:00
  • user avatar
    Ghassan Abou-Alfa
    @GABOUALFA
    Oct 19, 2019
    Lebanese protesting at best. Never stop learning #Lebanon
    Image
  • user avatar
    Ghassan Abou-Alfa
    @GABOUALFA
    Mar 22, 2019
    Eileen O’Reily named the incumbent of the Winthrop Rockefeller Chair of Meidcal Oncology @sloan_kettering . This is well deserved! Congratulations Eileen!
  • user avatar
    Ghassan Abou-Alfa
    @GABOUALFA
    Jan 19, 2023
    Delighted and honored! @gaboualfa awarded Adjunct Professorship @tcddublin @TrinityMedNews. Happy to see extended venue for @MSKCancerCenter @MSK_DeptOfMed work on #medicaldiplomacy
    Image
    9K
  • user avatar
    Ghassan Abou-Alfa
    @GABOUALFA
    Oct 15, 2021
    #HIMALAYA is positive! Congratulations to all patients. astrazeneca.com/content/astraz…! @sloan_kettering @GABOUALFA honored to have led #HIMALAYA globally!
  • user avatar
    Ghassan Abou-Alfa
    @GABOUALFA
    Nov 17, 2021
    What a beautiful morning welcoming @DrFadloKhuri by @EileenMOReilly and @GABOUALFA at @sloan_kettering. All delighted to continue celebrate and enhance the @AUB_Lebanon @sloan_kettering strong relationship and collaboration
    Image
  • user avatar
    Ghassan Abou-Alfa
    @GABOUALFA
    Sep 23, 2021
    Now with FDA approval, this is the final Efficacy of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation ja.ma/3CJ4cuD via @JAMAOnc part of @JAMANetwork. Congratulations to all!
    Image
    Efficacy of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation
    From jamanetwork.com
  • user avatar
    Ghassan Abou-Alfa
    @GABOUALFA
    Nov 6, 2020
    . @sloan_kettering waking up for another day caring for patients and discovering new therapy
    Image
  • user avatar
    Ghassan Abou-Alfa
    @GABOUALFA
    Mar 10, 2020
    Congratulations @EileenMOReilly on new @sloan_kettering chairmanship of the Human Research Protection Program (HRPP) IRB Head, and thanks Rober Wilson on an amazing job over the years. Thank you both on an examplary transition of leadership